Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Enterprise Value (2018 - 2025)

Health Catalyst's Enterprise Value history spans 8 years, with the latest figure at -$95.7 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 75.58% year-over-year to -$95.7 million; the TTM value through Dec 2025 reached -$95.7 million, up 75.58%, while the annual FY2025 figure was -$95.7 million, 75.58% up from the prior year.
  • Enterprise Value reached -$95.7 million in Q4 2025 per HCAT's latest filing, down from -$91.5 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$91.5 million in Q3 2025 to a low of -$455.2 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$320.5 million, with a median of -$345.8 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: plummeted 65.44% in 2021, then surged 76.36% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$445.0 million in 2021, then increased by 18.31% to -$363.5 million in 2022, then increased by 12.59% to -$317.7 million in 2023, then fell by 23.38% to -$392.0 million in 2024, then skyrocketed by 75.58% to -$95.7 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Enterprise Value are -$95.7 million (Q4 2025), -$91.5 million (Q3 2025), and -$97.3 million (Q2 2025).